首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal eIF4E(Ab-209) Antibody

  • 中文名: eIF4E(Ab-209)抗体
  • 别    名: mRNA cap-binding protein; eIF-4F 25 kDa subunit;
货号: IPDX41429
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/50-1/100 Human,Mouse,Rat
ICC 1/100-1/200 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesmRNA cap-binding protein; eIF-4F 25 kDa subunit;
Entrez GeneID1977;
WB Predicted band size25kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman,Mouse,Rat
ImmunogenPeptide sequence around aa. 207~211 (S-G-S-T-T) derived from Human eIF4E.
FormulationPurified antibody in PBS with 0.05% sodium azide.

+ +

参考文献

以下是关于eIF4E(Ab-209)抗体的3篇假设性参考文献示例(注:实际文献需根据具体实验验证,以下为模拟内容):

---

1. **文献名称**: *"Overexpression of eIF4E in Breast Cancer Correlates with Tumor Progression"*

**作者**: Smith J, et al.

**摘要**: 本研究利用eIF4E(Ab-209)抗体通过Western blot和免疫组化分析乳腺癌组织,发现eIF4E蛋白在侵袭性肿瘤中显著高表达,且与患者生存率降低相关,提示其作为预后生物标志物的潜力。

2. **文献名称**: *"mTOR Signaling Regulates eIF4E Phosphorylation in Cellular Translation"*

**作者**: Lee H, et al.

**摘要**: 通过eIF4E(Ab-209)抗体进行免疫沉淀和蛋白质印迹实验,证实mTOR通路通过调控eIF4E的磷酸化状态影响翻译起始效率,为靶向癌症治疗的机制提供依据。

3. **文献名称**: *"eIF4E Expression in Colorectal Cancer: A Clinicopathological Study"*

**作者**: Chen R, et al.

**摘要**: 采用eIF4E(Ab-209)抗体对结直肠癌组织进行染色,发现eIF4E的高表达与淋巴结转移和晚期TNM分期显著相关,支持其在肿瘤侵袭性中的作用。

---

**注意**:上述文献为示例,实际引用需根据具体抗体说明书或数据库(如PubMed)检索。建议通过抗体供应商(如CST的#209抗体页面)获取其官方引用的研究文献。

背景信息

The eIF4E (Ab-209) antibody is a specific immunological tool designed to detect eukaryotic translation initiation factor 4E (eIF4E), a critical protein involved in mRNA translation initiation. eIF4E binds to the 5' cap structure of mRNAs, facilitating their recruitment to the ribosome and regulating protein synthesis. Dysregulation of eIF4E is implicated in cancer, viral infections, and cellular stress responses, as its overexpression enhances translation of oncogenes and pro-growth mRNAs. The "Ab-209" designation typically refers to an antibody targeting a specific phosphorylation site or epitope within eIF4E. For example, phosphorylation at Ser209 (a common modification) modulates eIF4E’s activity and its interaction with other initiation factors. Researchers use this antibody in techniques like Western blotting, immunofluorescence, or immunoprecipitation to study eIF4E expression, post-translational modifications, or its role in signaling pathways (e.g., mTOR or MAPK). Validated in specific experimental models, the antibody helps elucidate mechanisms of translational control in diseases, therapeutic resistance, or viral replication. Its specificity is often confirmed using knockout cells or competitive peptides. When using this antibody, expected band sizes (~25 kDa for unmodified eIF4E) and tissue-specific expression patterns should be considered.

客户数据及评论

折叠内容

大包装询价

×